Cytosorbents Corp. buy Quitte
Start price
22.12.16
/
50%
€5.14
Target price
22.06.17
€6.48
Performance (%)
-23.68%
End price
22.06.17
€3.92
Summary
This prediction ended on 22.06.17 with a price of €3.92. The prediction for Cytosorbents Corp. disappointed with a performance of -23.68%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cytosorbents Corp. | 5.027% | 5.027% | -38.030% | -67.554% |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
Comments by Quitte for this prediction
In the thread Cytosorbents Corp. diskutieren
aktiviert
habe den Eindruck, diese Aktie ist jetzt zum Durchmarsch aktiviert
http://www.streetinsider.com/Corporate+News//Cytosorbents+%28CTSO%29+Announces+Launch+and+Initial+Sales+of+New+CytoSor/12358614.html
(Laufzeit überschritten)
Stopped prediction by Quitte for Cytosorbents Corp.
Cytosorbents Corp.
Start price
Target price
Perf. (%)
€9.12
06.11.18
06.11.18
€16.24
06.05.19
06.05.19
-24.33%
06.05.19
06.05.19
